Biologics have changed expectation and outcomes for rheumatoid arthritis (RA). However,
the optimal duration and sequence of therapy for this disease has yet to be determined. Also, …

Objective To determine whether quality of life in patients with systemic lupus erythematosus
(SLE) measured by the Short Form 36 (SF‐36) changes over time and which patient‐ and …

Objective Epidemiologic assessments of sufficiently large populations are required in order
to obtain robust estimates of disease prevalence and incidence, particularly when exploring …

Background Individuals with rheumatoid arthritis (RA) are at risk of developing cardiovascular
disease (CVD), but patient perceptions of CVD are not routinely assessed. We performed …

Background Elevated tumor necrosis factor (TNF)-α likely contributes to the excess
cardiovascular risk observed in rheumatoid arthritis. We compared the cardiovascular risk in …

Objective: To validate a model which predicts progression from undifferentiated arthritis (UA)
to RA, in a Canadian UA cohort. Methods: The prediction rule, comprising variables which …

Objective To evaluate excess mortality over time, comparing rheumatoid arthritis (RA)
patients with the general population. Methods We computed all‐cause mortality rates among …

Objective. To evaluate the prevalence and predictive factors of sustained remission in an
early rheumatoid arthritis (ERA) population. Predictive factors of sustained remission in ERA …

… Bindee Kuriya, MD, MS, Harvard School of Public Health, 677 Huntington Avenue, Boston,
MA 02115. E-mail: bindee.kuriya… Kuriya had full access to all of the data in the study and takes …

Objective To assess the proportion of, and factors associated with older adults with gout
receiving a serum urate (SUA) test after starting urate lowering therapy (ULT). Methods We …